000			02121 a2200517 4500
005			20250514225813.0
264		0	_c20050708
008			200507s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/j.bcp.2005.03.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aJakubíková, Jana
245	0	0	_aRole of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. _h[electronic resource]
260			_bBiochemical pharmacology _cJun 2005
300			_a1543-52 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aCaco-2 Cells
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aEnzyme Induction _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xphysiology
650	0	4	_aG2 Phase _xdrug effects
650	0	4	_aGlucuronosyltransferase _xbiosynthesis
650	0	4	_aHumans
650	0	4	_aIsothiocyanates
650	0	4	_aMAP Kinase Kinase Kinases _xphysiology
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMembrane Transport Proteins _xgenetics
650	0	4	_aMultidrug Resistance-Associated Protein 2
650	0	4	_aMultidrug Resistance-Associated Proteins _xgenetics
650	0	4	_aNAD(P)H Dehydrogenase (Quinone) _xbiosynthesis
650	0	4	_aPhosphatidylinositol 3-Kinases _xphysiology
650	0	4	_aProtein Serine-Threonine Kinases _xphysiology
650	0	4	_aProto-Oncogene Proteins _xphysiology
650	0	4	_aProto-Oncogene Proteins c-akt
650	0	4	_aSulfides _xpharmacology
650	0	4	_aSulfoxides
650	0	4	_aThiocyanates _xpharmacology
650	0	4	_aTranscription, Genetic _xdrug effects
700	1		_aSedlák, Ján
700	1		_aMithen, Richard
700	1		_aBao, Yongping
773	0		_tBiochemical pharmacology _gvol. 69 _gno. 11 _gp. 1543-52
856	4	0	_uhttps://doi.org/10.1016/j.bcp.2005.03.015 _zAvailable from publisher's website
999			_c15558701 _d15558701